GINA FERNANDO: Open Payments
NPI 1750907861 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,320 in 64 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $174 · 2025 $1,320
Food & beverage: $1,320
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $401 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $138 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $109 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| Lundbeck LLC | 3 | $65 |
| Novo Nordisk Inc | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Lilly USA, LLC | 3 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
Products named: VRAYLAR, CAPLYTA, Qelbree, AUSTEDO XR, ABILIFY ASIMTUFII, REXULTI, TRINTELLIX, INGREZZA.
Industry payments across IL — which companies pay providers there.
